Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: A case report

Amalia Schiavetti, M. D. De Pasquale, S. Di Salvo, F. Ventriglia, A. Clerico

Research output: Contribution to journalArticlepeer-review

Abstract

A 45-day-old patient was admitted with dyspnea, hepatomegaly, tachycardia, holosystolic murmur in the precordial region, and continuous murmur at the right hypochondrium. Four cutaneous angiomas were noted. Instrumental examinations revealed congestive heart failure and multipfocal lesions in the liver with typical features of hemangiomas. The therapy with subcutaneous interferon-alfa-2a (INF-α) was administered for 12 months with progressive regression of cutaneous hemangiomas, liver lesions, and cardiological alterations. IFN-α therapy was effective without any significant adverse effects.

Original languageEnglish
Pages (from-to)161-165
Number of pages5
JournalPediatric Hematology and Oncology
Volume20
Issue number2
DOIs
Publication statusPublished - Mar 2003

Keywords

  • Congestive heart failure
  • Hepatic hemangiomatosis
  • Interferon-α-2a

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Cancer Research
  • Management of Technology and Innovation

Fingerprint Dive into the research topics of 'Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: A case report'. Together they form a unique fingerprint.

Cite this